162 related articles for article (PubMed ID: 35770457)
81. Preconceptional paternal antiepileptic drugs use and risk of congenital anomalies in offspring: a nationwide cohort study.
Yang F; Yuan W; Liang H; Song X; Yu Y; Gelaye B; Miao M; Li J
Eur J Epidemiol; 2019 Jul; 34(7):651-660. PubMed ID: 30868347
[TBL] [Abstract][Full Text] [Related]
82. How to Manage Inflammatory Bowel Disease Patients When They Withdraw Anti-Tumour Necrosis Factor [Anti-TNF] Due to Severe Anti-TNF-Induced Skin Lesions? A Multicentre Cohort Study.
Cottron C; Treton X; Altwegg R; Reenaers C; Amiot A; Fumery M; Vuitton L; Peyrin-Biroulet L; Bouguen G; Dewit O; Nancey S; Caillo L; Roblin X; Beylot-Barry M; Rivière P; Laharie D
J Crohns Colitis; 2022 Aug; 16(8):1202-1210. PubMed ID: 35218189
[TBL] [Abstract][Full Text] [Related]
83. Safety of first year vaccination in children born to mothers with inflammatory bowel disease and exposed in utero to anti-TNFα agents: a French nationwide population-based cohort.
Luu M; Benzenine E; Barkun A; Doret M; Michiels C; Degand T; Quantin C; Bardou M
Aliment Pharmacol Ther; 2019 Dec; 50(11-12):1181-1188. PubMed ID: 31617226
[TBL] [Abstract][Full Text] [Related]
84. Increased Use of Medications for Erectile Dysfunction in Men With Ulcerative Colitis and Crohn's Disease Compared to Men Without Inflammatory Bowel Disease: A Nationwide Cohort Study.
Friedman S; Magnussen B; OʼToole A; Fedder J; Larsen MD; Nørgård BM
Am J Gastroenterol; 2018 Sep; 113(9):1355. PubMed ID: 29988041
[TBL] [Abstract][Full Text] [Related]
85. Association between tumour necrosis factor-α inhibitors and risk of serious infections in people with inflammatory bowel disease: nationwide Danish cohort study.
Nyboe Andersen N; Pasternak B; Friis-Møller N; Andersson M; Jess T
BMJ; 2015 Jun; 350():h2809. PubMed ID: 26048617
[TBL] [Abstract][Full Text] [Related]
86. Incidence, management, and course of cancer in patients with inflammatory bowel disease.
Algaba A; Guerra I; Marín-Jiménez I; Quintanilla E; López-Serrano P; García-Sánchez MC; Casis B; Taxonera C; Moral I; Chaparro M; Martín-Rodríguez D; Martín-Arranz MD; Manceñido N; Menchén L; López-Sanromán A; Castaño Á; Bermejo F
J Crohns Colitis; 2015 Apr; 9(4):326-33. PubMed ID: 25687203
[TBL] [Abstract][Full Text] [Related]
87. The impact of IBD medications on risk of pneumonia and pneumonia-related hospitalisation: a nationwide cohort study of 56 410 IBD patients.
Khan N; Patel D; Trivedi C; Pernes T; Kavani H; Xie D; Yang YX
Aliment Pharmacol Ther; 2022 Jan; 55(1):64-72. PubMed ID: 34664313
[TBL] [Abstract][Full Text] [Related]
88. Predicting, Preventing, and Managing Treatment-Related Complications in Patients With Inflammatory Bowel Diseases.
Beaugerie L; Rahier JF; Kirchgesner J
Clin Gastroenterol Hepatol; 2020 May; 18(6):1324-1335.e2. PubMed ID: 32059920
[TBL] [Abstract][Full Text] [Related]
89. Systematic review and meta-analysis of dermatological reactions in patients with inflammatory bowel disease treated with anti-tumour necrosis factor therapy.
Nigam GB; Bhandare AP; Antoniou GA; Limdi JK
Eur J Gastroenterol Hepatol; 2021 Mar; 33(3):346-357. PubMed ID: 32889976
[TBL] [Abstract][Full Text] [Related]
90. Anti-TNF agents in patients with inflammatory bowel disease and malignant melanoma--challenges in management.
Lee J; Clarke K
Int J Colorectal Dis; 2015 Dec; 30(12):1595-602. PubMed ID: 26349591
[TBL] [Abstract][Full Text] [Related]
91. Repeated Occurrences of Basal Cell Cancer in Patients With Inflammatory Bowel Disease Treated With Immunosuppressive Medications.
Khan N; Patel D; Trivedi C; Kavani H; Medvedeva E; Pernes T; Xie D; Lewis J; Yang YX
Am J Gastroenterol; 2020 Aug; 115(8):1246-1252. PubMed ID: 32453047
[TBL] [Abstract][Full Text] [Related]
92. The Risk of Serious Infections Before and After Anti-TNF Therapy in Inflammatory Bowel Disease: A Retrospective Cohort Study.
Holmgren J; Fröborg A; Visuri I; Halfvarson J; Hjortswang H; Karling P; Myrelid P; Olén O; ; Ludvigsson JF; Grip O
Inflamm Bowel Dis; 2023 Mar; 29(3):339-348. PubMed ID: 35776552
[TBL] [Abstract][Full Text] [Related]
93. Corticosteroid Use and Complications in a US Inflammatory Bowel Disease Cohort.
Waljee AK; Wiitala WL; Govani S; Stidham R; Saini S; Hou J; Feagins LA; Khan N; Good CB; Vijan S; Higgins PD
PLoS One; 2016; 11(6):e0158017. PubMed ID: 27336296
[TBL] [Abstract][Full Text] [Related]
94. Serial Tuberculin Skin Tests Improve the Detection of Latent Tuberculosis Infection in Patients With Inflammatory Bowel Disease.
Taxonera C; Ponferrada Á; Riestra S; Bermejo F; Saro C; Martín-Arranz MD; Cabriada JL; Barreiro-de Acosta M; de Castro ML; López-Serrano P; Barrio J; Suarez C; Iglesias E; Argüelles-Arias F; Ferrer I; Marín-Jiménez I; Hernández-Camba A; Bastida G; Van Domselaar M; Martínez-Montiel P; Olivares D; Rivero M; Fernandez-Salazar L; Nantes Ó; Merino O; Alba C; Gisbert JP;
J Crohns Colitis; 2018 Nov; 12(11):1270-1279. PubMed ID: 30052856
[TBL] [Abstract][Full Text] [Related]
95. Classical and recent advances in the treatment of inflammatory bowel diseases.
Sales-Campos H; Basso PJ; Alves VB; Fonseca MT; Bonfá G; Nardini V; Cardoso CR
Braz J Med Biol Res; 2015 Feb; 48(2):96-107. PubMed ID: 25466162
[TBL] [Abstract][Full Text] [Related]
96. Effectiveness of SARS-CoV-2 Vaccination in a Veterans Affairs Cohort of Patients With Inflammatory Bowel Disease With Diverse Exposure to Immunosuppressive Medications.
Khan N; Mahmud N
Gastroenterology; 2021 Sep; 161(3):827-836. PubMed ID: 34048782
[TBL] [Abstract][Full Text] [Related]
97. Safety Analysis of Preoperative Anti-TNF-α Therapy in Pediatric IBD After Intestinal Resection: A Systematic Review and Meta-analysis.
Bajzát D; Kéri AF; Imrei M; Kói T; Párniczky A; Hegyi P; Kovács K; Váncsa S; Müller KE
Inflamm Bowel Dis; 2023 Dec; 29(12):1971-1980. PubMed ID: 36789751
[TBL] [Abstract][Full Text] [Related]
98. Anti-tumor Necrosis Factor Alpha Versus Corticosteroids: A 3-fold Difference in the Occurrence of Venous Thromboembolism in Inflammatory Bowel Disease－A Systematic Review and Meta-analysis.
Székely H; Tóth LM; Rancz A; Walter A; Farkas N; Sárközi MD; Váncsa S; Erőss B; Hegyi P; Miheller P
J Crohns Colitis; 2024 May; 18(5):773-783. PubMed ID: 37952112
[TBL] [Abstract][Full Text] [Related]
99. Association between Immunosuppressive Drugs and Coronavirus Disease 2019 Outcomes in Patients with Noninfectious Uveitis in a Large US Claims Database.
Sun Y; Miller DC; Akpandak I; Chen EM; Arnold BF; Acharya NR
Ophthalmology; 2022 Oct; 129(10):1096-1106. PubMed ID: 35588945
[TBL] [Abstract][Full Text] [Related]
100. Paternal preconception exposure to non-steroid anti-inflammatory drugs or opioids and adverse birth outcomes: A nationwide registry-based cohort study.
Lund K; Garvik OS; Aagaard SM; Jølving LR; Larsen MD; Damkier P; Nørgård BM
Andrology; 2023 Nov; ():. PubMed ID: 37941509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
